NL-OMON29781招募中2 期
Influence on brain perfusion and metabolism through pharmacologic agents - perfusie_pharma
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99(—)
入选标准
- •1) a diagnosis of MS, according to the McDonald criteria with a secondary progressive disease course and a disease duration of between ten and fifteen years
- •2) age 18-60 years
- •3) informed consent
排除标准
- •1) use of systemic corticosteroids in the eight weeks before inclusion into the trial
- •2) use of immunomodulatory treatments for MS
- •3) a history of cerebral pathology other than MS (cerebral infarct, cerebral haemorrhage, Parkinson's disease, Alzheimer's disease, cerebral vasculitis, brain absces)
- •4) diabetes mellitus, cardiac arrhytmia, prolonged qt time on ecg, pregnancy or breast feeding.
研究者
相似试验
进行中(未招募)
不适用
Influence on brain perfusion and metabolism through pharmacologic agentsMedDRA version: 8.1Level: PTClassification code 10028245Term: Multiple sclerosisMultiple SclerosisEUCTR2006-004318-42-NLDepartment of Neurology UMCG
已完成
不适用
Changes in cerebral blood flow and oxygenation during induction of general anesthesia with sevoflurane or propofol ;prospective randomized control trialThe patient undergoing elective operation under general anesthesiaJPRN-UMIN000013903ihon University School of Medicine20
已完成
不适用
Examination of neuronal and metabolic effects of long-term transcutaneous vagus nerve stimulation in obese adult malesE66ObesityDRKS00012302niversitätsklinik zu Lübeck Medizinische Klinik 1 - Klinik für Neurologie40
尚未招募
不适用
Changes in cerebral blood flow due to the involvement of nurses in a remote environment in cognitive rehabilitatioDementiaJPRN-UMIN000041231Osaka Medical College10
尚未招募
不适用
Metabolic and neurovascular brain plasticity in amyloid-positive older people with metabolic risk factorsMetabolic risk factors defined by ATP-III-criteriaAmyloid deposition as indication of preclinical Alzheimer’s diseaseDRKS00013501Deutsches Zentrum für Neurodegenerative Erkrankungen e.V.300
